Pathos AI vs Target Pharmacy

Side-by-side comparison of AI visibility scores, market position, and capabilities

Target Pharmacy leads in AI visibility (78 vs 52)
Pathos AI logo

Pathos AI

ChallengerHealthcare & Life Sciences

AI Oncology

Clinical-stage AI company raised $365M Series D at $1.6B for world's largest multimodal oncology AI; Novo Nordisk partnership; $467M total;

AI VisibilityBeta
Overall Score
C52
Category Rank
#289 of 596
AI Consensus
82%
Trend
stable
Per Platform
ChatGPT
48
Perplexity
54
Gemini
50

About

Pathos AI is a clinical-stage AI company building the world's largest multimodal oncology AI platform, combining pathology imaging, genomics, clinical records, and treatment outcome data to power precision cancer care. Founded by oncologists, pathologists, and AI researchers, Pathos has assembled a dataset at a scale that gives its models a meaningful edge: by ingesting vast quantities of multimodal cancer data, its platform can predict treatment responses, identify biomarkers, and guide therapy selection with a level of accuracy that single-modality systems cannot match.\n\nThe platform serves oncologists and cancer centers by providing AI-augmented pathology reads, treatment outcome predictions, and clinical trial matching. Pathos's AI can analyze whole-slide pathology images in combination with molecular and clinical data to generate insights that inform diagnosis and treatment decisions. The company has also built partnerships with pharmaceutical companies — including Novo Nordisk and Prelude Therapeutics — to use its platform for drug development and clinical trial design, adding a biopharma revenue stream alongside its clinical business.\n\nPathos raised $365M in a Series D round at a $1.6B valuation, bringing total funding to $467M. The Series D was one of the largest oncology AI fundraises in history and included backing from top-tier life sciences investors. The Novo Nordisk and Prelude partnerships validate the platform's scientific depth and its utility across both clinical care and drug development. As of 2025–2026, Pathos is advancing toward direct clinical deployment and regulatory submissions, positioning itself as a core infrastructure layer for the future of AI-guided cancer treatment.

Full profile
Target Pharmacy logo

Target Pharmacy

LeaderHealthcare

Pharmacy Retail

CVS Health-operated pharmacy inside Target (NYSE: TGT) stores serving 100M weekly shoppers; $1.9B 2015 Target-to-CVS pharmacy acquisition creating store-within-store pharmacy integrated with Target Circle loyalty.

AI VisibilityBeta
Overall Score
B78
Category Rank
#34 of 596
AI Consensus
83%
Trend
stable
Per Platform
ChatGPT
78
Perplexity
74
Gemini
73

About

Target Pharmacy refers to the pharmacy services within Target Corporation's (NYSE: TGT) retail stores — providing prescription dispensing, immunizations, and health consultations to Target shoppers combining pharmacy errands with retail shopping. In 2015, Target sold its pharmacy and clinic operations to CVS Health (NYSE: CVS) for $1.9 billion, converting the in-store locations to CVS Pharmacy branding under a long-term licensing agreement — making what shoppers call "Target Pharmacy" operationally a CVS pharmacy located inside Target's 1,900+ US stores, operating under CVS management while Target shoppers earn Target Circle rewards on eligible pharmacy purchases.

Full profile

AI Visibility Head-to-Head

52
Overall Score
78
#289
Category Rank
#34
82
AI Consensus
83
stable
Trend
stable
48
ChatGPT
78
54
Perplexity
74
50
Gemini
73
47
Claude
78
47
Grok
79

Key Details

Category
AI Oncology
Pharmacy Retail
Tier
Challenger
Leader
Entity Type
brand
company

Capabilities & Ecosystem

Capabilities

Only Pathos AI
AI Oncology
Only Target Pharmacy
Pharmacy Retail
Target Pharmacy is classified as company (part of CVS Health).

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.